Abbott Laboratories (ABT) operating KPIs
ABTNYSEPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Jul 28, 2026Score 14/3036% above fair value
$106.20+1.63 (+1.56%)
Close on Oct 30, 2026Market cap $183.77BP/E 34.1Yield 2.26%
Abbott Laboratories non-GAAP Adjusted Selling, General & Administrative Expense ($M) ($M)
Form 8-K Non-GAAP Reconciliation Tables
Latest, Q3 2026
3,505
Period ended Sep 30, 2026
Change on a year earlier
+16.7%
3,004 in Q3 2025
History
48 quarters
Since Q4 2014
Sources
44
Documents cited below
Quarterly history
Hover a value to see the sentence it was read from; calculated values show their formula
Cite this data
StockData. (2026). Abbott Laboratories Non-GAAP Adjusted Selling, General & Administrative Expense ($M) ($M), quarterly Q4 2014–Q3 2026 [Data set]. Compiled from Abbott Laboratories SEC filings and investor materials. https://stockdatahq.com/stocks/abt/kpis/ng-sga
See every metric in the Abbott Laboratories KPI table. Data updated Oct 29, 2026.